CoEHAR, University of Catania: 4 theses on THR
Catania, April 29, 2024 - This morning, as part of the April graduation session of the Bachelor's Degree in Biotechnology at the University of Catania, four more theses on the…
HOW TO CHANGE HEALTH POLICY STRATEGIES? SMOPHED STUDY: INVESTIGATION ON VAPERS AND SMOKERS ACCESSING EMERGENCY HOSPITAL SERVICES.
But how much would harm reduction and the reduction of smoking-related diseases affect international health policy strategies? Would there be fewer hospital admissions without conventional cigarette smoke? The answer will be provided by questionnaires administered to over 3000 hospitalized patients whose smoking habits and potential use of non-combustion products will be analyzed to assess the causes of hospital admission and the subsequent outcomes of the diseases identified.
International Young Researcher Awards Ceremony at CoEHAR, University of Catania, Italy
Dr. Nikolina Kastratovic of the Faculty of Medical Sciences at the University of Kragujevac, Serbia, was honored with the award for her outstanding project on the immunomodulatory effects of combustible and electronic cigarettes on human cells.
HOW TO REDUCE THE HARM CAUSED BY CIGARETTE SMOKE ON ORAL HEALTH AND TEETH?
The data from these works as a whole can be used to assess the impact in terms of risk/benefit ratio of the regular use of combustion-free products, assisting the efforts of public health authorities in encouraging smokers to quit, especially those who perceive their smoke-damaged smile as a barrier to personal health or work and social relationships.
Groundbreaking Global Initiative to Investigate Oral Health Impacts of Combustion-Free Nicotine Delivery Alternatives: the SMILE Study
The study has been designed with the help of experts from Germany, UK, Italy, Poland, Moldova, and Indonesia. SMILE study is being conducted in four dental clinics across four different countries (Italy, Poland, Moldova, and Indonesia). Volunteer enrollment was completed in August 2023 and results will be expected to be available in 2025.
MAGNIFICAT Project moves forward with international workshop success
On Tuesday, February 20th, the MAGNIFICAT Project, coordinated by CoEHAR, hosted a pivotal workshop in Warsaw, Poland, to bring together all partners involved in in-depth discussions and hands-on exercises focusing…
Cochrane and New England Journal: e-cigs surpass traditional methods in smoking cessation potential
Data confirms that there is high certainty that nicotine electronic cigarettes increases quit rates compared to nicotine replacement therapy.
Giovanni Li Volti reconfirmed director of CoEHAR
The CoEHAR Council (made up of 71 of the 95 members of the Center of Excellence of the University of Catania), meeting in an online session, reconfirmed their trust in…
Gambling: Brain Magnetic Stimulation, a New Frontier with Promising Results
A group of researchers from the University of Catania conducted a review on numerous available databases to assess the effectiveness of protocols using magnetic stimulation to treat gambling disorders. A…
MAGNIFICAT project: dual user and harm reduction potential
On 19th January, in Hotel Palace Catania, there was a Kick-Off meeting held by CoEHAR, its Partners: ABF GmbH from Germany, PRATIA MTZ from Poland and supporting Parties such as…
WhatsApp Image 2023-11-21 at 13.43.34
Unveiling the truth of aerosol emission: far fewer hazardous compounds in heated tobacco products than in cigarette smoke
“ Our comprehensive analysis underscores that the aerosol from heated tobacco products (HTPs) contains markedly fewer and substantially lower concentrations of toxic compounds compared to traditional cigarette smoke," Professor Roberto Sussman, first author of the study, stated. "However, despite the reduced levels, the existence of harmful compounds in HTPs and e-cigarettes, notably aldehydes, necessitates vigilant oversight."
BREAKTHROUGH STUDY REVEALS VARENICLINE AND COUNSELING EFFECTIVE FOR DUAL USERS IN SMOKING CESSATION
The study found that the antismoking medication varenicline can increase rates of smoking abstinence without causing serious adverse events.
CoEHAR: NO HEALTH RESPIRATORY EFFECTS REPORTED WITH ECIG SUBSTITUTION FOR SMOKING
In their work “Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review”, researchers analyzed 16 studies from 20 publications: most of the studies showed no difference in respiratory parameters. This indicates that electronic nicotine delivery systems substitution for smoking likely does not result in additional harm to respiratory health.
REPLICA STUDY: CoEHAR research shows minimal to zero cancerogenic effects of e-cigarettes
Replica researchers performed a standard toxicology battery of three assays used for product assessment and regulatory applications.
DiaSmokeFree Working Group Challenges American Diabetes Association Guidelines on E-Cigarette Use
The DiaSmokeFree Working Group send a letter to the American Diabetes Association (ADA) expressing concern and seeking correction of a couple of statements in the ADA guidelines regarding the use…
70,000 AMERICAN VAPERS ATTEST THAT SWEETER ECIG FLAVORS HELP TO QUIT AND PREVENT RELAPSES INTO SMOKING
An online survey, conducted on approximately 70,000 exclusive and non-exclusive American adult vapers, highlighted that the most utilized flavors to quit smoking are those of fruit, baked goods, and chocolate. These flavors are considered helpful in preventing and reducing the risk of relapses, but concerns about youth addiction are pushing government to enact strict state regulations
Replica researchers at CORESTA 2023, Mexico
On behalf of CoEHAR, the Center of Excellence for the acceleration of Harm Reduction, Dr. Lia Emma, researcher of the Replica project, will attend the conference to present the abstract "Cytotoxicity evaluation of vanillin in electronic cigarette liquids on human aortic artery endothelial cells”.
Cochrane: Some medicines and e-cigarettes can help people to quit smoking
According the authors, for every 100 people, 10 to 19 are likely to quit using an e-cigarette; 12 to 16 using varenicline; and 10 to 18 using cytisine. This is compared to the 6 in 100 people likely to quit when using no medicine/e-cigarette or placebo. People using two forms of nicotine replacement therapy at the same time, for example, a combination of nicotine patch and nicotine gum, seemed to have similar rates of quitting to people using e-cigarettes, varenicline and cytisine.
CoEHAR advocate for e-liquids regulation: first ever reported urticaria case associate with vaping
For the first time, CoEHAR researches reported a case of urticaria following the inhalation of a specific flavoring in an e-liquid used during a switching trial. Although linked to a specific component of the liquid used, this finding highlight the need of further regulation of e-liquid.
ENDS for smoking cessation: CoEHAR published the umbrella review protocol
"We decided to provide the widest overview of clinical evidence on smoking submission and quit rates and absitance rates of e-cigarettes to researchers and clinicians” explain dr. Renèe O’Leary, author of the protocol.
SRNT-E 2023: varenicline and vaping cessation at the London conference
On Monday 11 September, prof. Caponnetto has presented "Varenicline and counseling for vaping cessation: A double-blind, randomized, parallel-group, placebo-controlled trial".
6th Scientific Summit on THR – Athens
Prof. Giovanni Li Volti, director of CoEHAR e dr. Renèe O'Leary will be in conference as a speakers with two interesting abstract on Harm Reduction and CoEHAR research.
Doctors’ Survey: Italy results
86% of physicians believe that combustion is more harmful than nicotine. 64%-77% of physicians believe that nicotine directly causes various smoking-related conditions, with 19% to 32% believing strongly.
Doctors Survey: international webinar
A panel of tobacco control experts, including Dr. Sudhanshu Patwardhan, Dr. Riccardo Polosa, and Dr. Jed Rose, discuss their views on how the survey results might impact smoking cessation and tobacco harm reduction efforts.
Nearly 80 percent of Doctors Worldwide Mistakenly Believe Nicotine Causes Lung Cancer
While an average of 87% of doctors at least moderately agree helping patients quit smoking is a priority, it is troubling that on average 74% mistakenly believe nicotine causes a range of illnesses from lung cancer to COPD.
Replica project: degree at the University of Catania
The summer graduation session at the University of Catania was held last week. Among the works of the new graduates in the biotechnology degree courses are also two theses on…
CoEHAR interview: Ang Sun
Interview with prof. Prof. Ang Sun, of the Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University (USA),…
CoEHAR interview: Robert Sussman
CoEHAR interview with prof. Robert Sussman of Universidad Nacional Autónoma de México and Visiting Professor of the University of Catania. How many smokers are there in Mexico? e-cigarettes and heat…
CoEHAR interview: Attaullah Ahmadi
CoEHAR interview with prof. Attaullah Ahmadi, visiting researcher della French School of Public Health e Global Health Focus presso il Dipartimento di Medicina Clinica e Sperimentale dell'Università di Catania. https://www.youtube.com/watch?v=MeaAmfnw4WU
Italian Parliament – Polosa: “Integrating the principle of harm reduction to bring smokers from 25 to 5%”
This was stated by prof. Riccardo Polosa, founder of CoEHAR, Research Center for the reduction of harm from smoking, and full professor of Internal Medicine at the University of Catania, yesterday in a hearing in the Social Affairs Commission of the Chamber, in the context of the examination of the Communication from the Commission to the European Parliament and the Council on the ‘European plan to fight against cancer’.
New seminar at CoEHAR on THR in Afghanistan
“TOBACCO HARM REDUCTION IN AFGHANISTAN: EXPERIENCES, CHALLENGES, AND RECOMMENDATIONS”, new seminar at CoEHAR, University of Catania. On Friday, 14th July 2023 at 12 am CEST, Room 6 in the Biological Tower, Dr.…
CoEHAR hosts a lectio magistralis with prof. Ang Sun of Temple University
Prof. Ang Sun of Temple University (USA) will hold a seminar on THR research on 11th July at 11am at the University of Catania.
Just published the first randomized controlled trial of varenicline for vaping cessation
The use of the drug combined with an innovative vaping cessation counseling program was safe and effective for quitting e-cigarettes. The combined approach also decreased the chances of relapsing back to vaping and smoking.
Diasmoke Working Group in Warsaw: how to address the smoking issue among diabetes patients?
During the 2023 edition of the GFN, a pool of international diabetologists, coordinated by CoEHAR, addressed the issue of cigarette smoking among diabetes patients, setting new international treatment guidelines to be published soon.
VERITAS COHORT: the project takes off as 27 countries are involved all over the World
In May, CoEHAR has launched one of its most ambitious project, the Veritas Cohort study. Now, more than 400 people from 27 different countries are involved and numbers keep increasing.
At GFN 2023, SAB Diasmoke second meeting
GFN 2023 will start tomorrow at Varsavia. The 10th edition of the Global Forum on Nicotine, from 21 to 24 June, will host more events dedicated to harm reduction research. During this edition will be also the second meeting of SAB Diasmoke. Diabetologists and experts on THR signed the guidelines on the treatment of smokers with diabetes.
CoEHAR hosts a seminar with prof. Robert Sussman, Universidad Nacional Autónoma de México
Prof. Roberto Sussman of the Universidad Nacional Autónoma de México, and actually visiting professor in Catania University, will hold a seminar on THR research on 14th June at 3pm at the University of Catania.
CoEHAR, UNIVERSITY OF CATANIA: HARM REDUCTION IS THE WEAPON TO DEFEAT SMOKE
“It is a fact that in Italy there are millions of smokers who are unwilling or unable to quit smoking – explained prof. Riccardo Polosa, founder of CoEHAR - These smokers do not accept to be medicalized because of their smoking habit and in Italy, even today, we do not have a health policy that takes care of these people. Risk reduction is the solution. In countries with a liberal approach, such as Sweden or England, which have chosen to open up to alternative nicotine release tools by promoting them in the cessation paths for heavy smokers, the prestigious smoke-free goal is being reached. It is time to follow these virtuous examples also in Italy".
Hereditary cancer and genetic background, CoEHAR at the Temple University
"From biologic mechanisms to theragnostic paths in the Hereditary Cancer Syndromes: germline mutations as a therapeutic target" is the title of the meeting held at the Temple University, Friday, May 12. Although hereditary cancer…
EU: public consultation on the “Evaluation of the legislative framework for tobacco control”
The European Commission has launched a public consultation on the "Evaluation of the legislative framework for tobacco control" which allows citizens, experts, industries and all stakeholders to express their opinion on the revision of the Tobacco Directive (TPD) through filling in a multiple-choice questionnaire, and sharing a final opinion of up to 500 characters.
Meeting in Serbia with CoEHAR partners of the Replica project
Today, Tuesday May 09, the University of Kragujevac in collaboration with the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) University of Catania (Italy) has organized in Serbia a Scientific…
Gambling causes mental illness and is often associated with psychopathological illnesses
A group of researchers from the CoEHAR of the University of Catania, led by prof. Pasquale Caponnetto, conducted a systematic review that analyzed the main and most recent forms of…
CoEHAR researchers’ “guidebook”: how to identify data misinterpretations in ecig studies
Researchers from CoEHAR's In Silico Science project have developed a two-step technique to identify spin bias, research reporting that results in an intentional or unintentional misinterpretation of research results.
Rome – Health, focus on “Global clinical risk: causes and intervention strategies”
One of the speakers of the event, moderated by Prof. Carla Bruschelli, was Prof. Riccardo Polosa, founder of CoEHAR, Center of Excellence for the acceleration of Harm Reduction, and professor of Internal Medicine at the University of Catania. The subject of his speech was the patient with COPD (Chronic Obstructive Pulmonary Disease) with addiction to smoking, which he defined as "a difficult patient, because he has a long history that has created a strong alliance with cigarettes. Therefore, giving up smoking leads him to a great form of distress, because it represents a loss”.
UK launch the first “swap to stop” scheme in the World
Riccardo Polosa: "I applaud the new British initiative: we will follow up on the details but it is already clear that this is a revolutionary change that we hope will be followed by many other countries. It is a concrete and rational action of health policy"
Jakarta: academic diplomacy initiatives to fight smoking addiction
We are working to strengthen the dialogue and scientific collaboration between Indonesian and Italian universities and the collaboration between Catania and Jakarta is an important first step in this direction.
CEASEFIRE: first study in the world to assess the efficacy and safety of heated tobacco products and e-cig as a valid smoking cessation tool
“We observed an improvement in exercise tolerance in participants compared to the initial levels: many patients from the first month declared that they have more breath and to feel less fatigue in small but important daily activities such as climbing stairs or doing household” - added prof. Pasquale Caponnetto, professor of clinical psychology at DISFOR of the University of Catania and CoEHAR member.
International webinar in Indonesia
The Universitas Padjadjaran is organizing an online webinar dedicated to tobacco harm reduction strategies in collaboration with the researchers of the Replica project: "Harm Reduction Efforts in Smoking" will be held on Friday, 7th April 2023 at 3 pm GMT+7.
Smile study at the Polish Periodontal Society
uring the latest meeting of the Polish Periodontal Society held by Polish Society of Periodontology and Periodontology Chapter of the Polish Dental Society, prof. Jan Kowalski of the Department of Periodontology, Medical University of Warsaw, Warsaw in Poland was attend for the SMILE Study project.
EVO NXT: Exciting business festival kicks off in Málaga, Spain
As a result, expectations are high for an event that is all about e-cigarettes, heat-not-burn and cannabidiol (CBD) products, pouches and other smokeless alternatives. To meet these expectations, Messe Dortmund has launched the new EVO NXT industry festival which is making its début on 10 and 11 March at the Palacio de Ferias y Congresos de Málaga (FYCMA) in Málaga, Spain.
Schizophrenia spectrum disorders patients: smoking also harms friends and relatives
The high number of cigarettes smoked every day by patients with severe mental disorders does not only harm individual smokers but also their parents and the people around them. The habit of smoking is perceived as harmful and also causes discomfort to those close to patients with schizophrenia who can even smoke 60 cigarettes a day.
27th February: Replica 2.0 Kick-off meeting
From Monday 27th February to Thursday 2nd March, CoEHAR will host the kick-off meeting of the REPLICA 2.0 project. A team of international researchers from different countries will attend the event coordinated by CoEHAR to launch the new era of Replica.
State-of-the-art review article concludes that e-cigarettes may offer health benefits to COPD patients
The ground-breaking review article "Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: Current and emerging evidence" published in Expert Review of Respiratory Medicine discusses existing and future options for COPD smokers who have difficulty quitting smoking. It also systematically reviews the current literature about e-cigarettes and heated tobacco products. The article is authored by CoEHAR researchers of the University of Catania together with British respiratory physicians at Guy’s & St Thomas’ Hospitals in London.
Polosa inaugurates 2023 with 2 new records
A record that is associated with another incredible scientific result of the CoEHAR team which closes 2022 with a record: the group of scientists affiliated with the research center in Catania has managed to achieve, in just 4 years, 128 scientific publications in prestigious journals dedicated to Harm Reduction.
Anti-vaping narrative driven by low quality science goes undetected by editorial quality checks
In their Commentary “A tale of flawed e-cigarette research undetected by defective peer review process” published in Internal and Emergency Medicine, top harm reduction researchers Riccardo Polosa, Founder of the CoEHAR, and Konstantinos Farsalinos, from University of West Attica, denounce the danger of an escalation in the promotion and dissemination of an anti-vaping narrative supported by evidence of the lowest quality.
E-cigarette summit – 9th December 2022
The E-Cigarette Summit will be held at the Royal College of Physicians (RCP) in London on Friday 9th December 2022. Alongside a milestone anniversary for the Summit, it is also 60 years since the RCP first published its ground breaking report “Smoking and Health”, which laid the foundations for tobacco control.
New frontiers in the care of people with schizophrenia: low-risk products are a valid substitute for smoking
According to a qualitative analysis that involved the health personnel responsible for accompanying patients with schizophrenic spectrum disorders in their therapeutic paths, tobacco addiction is highly harmful and widespread among patients suffering from these disorders: doctors, psychologists and healthcare professionals in general have a positive view of smokeless instruments, which are considered an excellent substitute for smoking.
Risk reduction in Italy: Rome 9th November
"Risk reduction as a public health strategy to eradicate cigarette smoking", is going to be discussed in Rome on Wednesday 9th November as part of a conference promoted by Motor Health in the "Sala Cristallo" of Hotel Nazionale in Piazza Montecitorio.
CNBC Dubai: Prof. Polosa speaker on Harm Reduction
Among the distinguished speakers, also the expected speech by prof. Riccardo Polosa, founder of CoEHAR.
Riccardo Polosa at the National Congress of the Italian Society of Internal Medicine
Harm Reduction strategies were the subject of a speech by prof. Polosa during the National Congress of the Italian Society of Internal Medicine. Focus of this year edition, the management of…
Smile Study: A smile to quit smoking
Smile study is a CoEHAR research project that aims to assess the impact of cigarette smoking on oral health in four different countries around the world. Italy, October 2022- It…
Mirroring human mental processes through artificial intelligence can open new frontiers in clinical medicine
Just published in the journal Internal and Emergency Medicine a commentary that illustrates the potential of machine learning in analyzing and processing large amounts of clinical and laboratory information, using…
Replica project results at the XVI FISV Congress in Naples
The Replica project team activity and the results of the studies on the reduced cytotoxicity and inflammation induced by cigarette smoke and ENDS aerosol will be presented during the XVI edition of the Congress of the Italian Federation of Life Sciences (FISV), which represents over 10.0000 Italian scientists and which will take place from 14 to 16 September 2022 in Naples
75th Tobacco Science Research Conference: CoEHAR in New Orleans
The meeting “75th Tobacco Science Research Conference” is an incredible opportunity for researchers and professionals to discuss, analyze and deepen the latest news on tobacco harm reduction strategies, including the necessary steps to develop the scientific activity and the engagement of the sector
Replica Project at the Scientific Summit on Tobacco Harm Reduction
The 5th Scientific Summit on Tobacco Harm Reduction: Novel products, Research & Policy, is organised by SCOHRE, the International Association on Smoking Control & Harm Reduction, and will be held on…
Letter to the Malaysian government on tobacco control
The most important scientists on harm reduction research recently sent a letter to the government of Malaysia to alert them about the consequences that may derive from their proposed prohibition…
Polosa and Goniewicz the world’s most influential e-cigarette researchers, a new bibliometrics analysis concludes
The mapping of Global Research on electronic cigarettes showed that prof. Riccardo Polosa (CoEHAR Center of Excellence for the Acceleration of HArm Reduction, University of Catania) and prof. Maciej L. Goniewicz (Roswell Park Comprehensive Cancer Center, USA) are the most influential authors and the most important researchers in the e-cigarettes research field.
Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”
The prestigious American Journal of Respiratory and Critical Care Medicine published a comment by researchers from CoEHAR and the University of Messina regarding a US studies that concluded that “former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms”. According to the Italian authors “the significance of the findings needs careful review”.
Evidence for Clinicians: E-Cigarettes a Better Chance at Health
The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians
US: end of teen nicotine vaping epidemic and eradication of tobacco smoking
The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.
First study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes
A recent randomized controlled trial of varenicline (Chantix) combined with psychological support has significantly increased the chance of quitting smoking for 300 smokers with type 2 diabetes mellitus
The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature
Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.
CoEHAR round table: evidence for tobacco harm reversal from combustion free products
On Tuesday 12 and Wednesday 13 April, a seminar on Harm Reduction has been organized by CoEHAR at the Biologic Tower of the University of Catania, with the participation of…
CoEHAR opens its doors to researchers from Ukraine
CoEHAR, Center of Excellence for the acceleration of Harm Reduction of the University of Catania, opens its doors to researchers from Ukraine
Smoking spoils dental whiteness: the ODON study
In terms of public health, these studies may have a tremendous impact. People who feel that bad breath or their teeth appearance are a major problem, can be massively influenced by aesthetic considerations to stop smoking.
The geography of Harm Reduction: while snus and chewing tobacco are distributed worldwide, the literature is incomplete and deceiving
The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa
1st-Level online Master of the CoEHAR: “Smoking cessation and Harm reduction”
The University of Catania and the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) are glad to announce the call for applications for the 1st-Level Master on Smoking…
Stress at work? For smokers who want to quit, the benefits derive from the gestures given by the use of zero-risk devices
The study determined for the first time that the use of reduced-risk products can significantly reduce nicotine addiction, especially in the presence of harmful behavioural aspects.
Harm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed
"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"
Polosa and Li Volti drumstick the Lancet
The Lancet Oncology published in August an article which clarified the positions of CoEHAR leaders on some unfounded news spread in recent months. In June, Lancet has published an article…
CoEHAR’s study confirms beneficial effects of ecig on copd smokers
CoEHAR's researchers have just published the longest clinical follow-up of E-cigarette users ever reported. The study “COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up” explores the long term effects of E-cigarette use in patients with chronic obstructive pulmonary disease (COPD) and confirms that regular use can ameliorate objective and subjective COPD and is long lasting
Harm reduction is a flavoured journey in global tobacco control
New studies show flavoured vaping products are more effective for adults who want to quit smoking for good without relapsing.
Incriminating ecig no matter what is becoming a new national sport
An article published in the Lancet triggers the reaction of the scientific community that supports the tobacco harm reaction policies.
The Smile Study has officially started the operational phase
On 22 July 2020, Smile Study started officially the operational phase of the projects with the training on the equipments and the visiting of first subjects enrolledDr. Elbert Waller of the Inspektor Research Systems has been welcomed in Catania for for the conduction of a training on the latest innovative technologies in dental diagnostic
CoEHAR Unict: A call is open for 4 Research Fellowships
Catania, 8 June 2020 - The selection procedure for the award of 4 Research Fellowships is open to young graduates in various discipline: the deadline is June 26, 2020. The selection is part of the activities and research projects promoted by the COEHAR, the Center of Excellence for the Accelleration of Harm Reduction of the University of Catania, founded by Prof. Riccardo Polosa.
Catania Conversation is a new CoEHAR project which brings together Journalists, Scientists and Opinion Leaders experts in harm reduction from all over the world
On the occasion of the World No Tobacco Day 2020, CoEHAR will organize anOnline Masterclass on 29th May 2020 dedicated to introduce Journalists, Scientists and Opinion Leaders to tobacco harm reduction principle and educate them on the views of the international scientific community.
CoEHAR evaluates the new APPs created to help quit smoking
Catania, Italy, April 21 - A new article by the researchers from the CoEHAR confirms that APPs for smartphones and tools for detecting and monitoring the rituality linked to smoking…
First International podcast by Riccardo Polosa for the Foundation for a Smoke Free World
Prof. Riccardo Polosa has been invited to join Global Health Perspectives with Derek Yach, a series of podcast on serious issues on public health. The Foundation for a Smoke Free…
CoEHAR, heart that beats in the world
These last days we have been receiving hundreds of messages of solidarity from our partners around the world. Hundreds of our doctors and researchers are on the front lines fighting…
Behavioral Interventions can help smokers with diabetes quit with a greater likelihood of success. However, structured programs are needed
The results were included in the review "Behavioural therapy for people with diabetes who smoke: a scoping review," published in the Journal of Primary Care and Community Health: it is now clear that persons living with diabetes are not the subject of targeted treatments and that there is ample room for progress. It seems that more structured and intensive therapies could benefit these persons in bidding farewell to cigarette smoking, while little is still known about the possible benefits of combining behavioral therapies and nicotine replacement pharmacological therapies.
UNICT student awarded with the KAC scholarship on THR
Currently engaged in her internship at the laboratory of Prof. Massimo Caruso, co-project leader of the Replica project, Chiara Giardina, thanks to the work conducted in the laboratories of CoEHAR in Catania, managed to participate in and obtain the KAC scholarship.
VapitalyPRO
An exclusively B2B event focused on networking and business within the vaping sector, taking place at the new Fiera di Roma exhibition center.
Vapitaly a Verona
A three-day B2B & B2C exhibition held at the Veronafiere fairground. Saturday and Sunday are open to the public, while Monday is reserved for industry operators.
8th World Congress of the World Association of Dual Disorders (WADD) and the 26th Congress of the Spanish Society of Dual Disorders (SEPD)
The congress will focus on the integration of neuroscience findings with clinical practices in treating mental disorders and addictions. It promises a multidisciplinary approach, featuring prominent speakers including Nora Volkow,…
5th International Conference on Cell and Experimental Biology
Hosted by the United Scientific Group, it aims to bring together influential pioneers and thought leaders in the field of cell and experimental biology to share knowledge and ideas through…
New report from The Royal College of Physician: positive impact of E-Cigarettes
The Royal College of Physicians has assessed the available evidence on the use of e-cigarettes, from health effects to the issue of youth vaping, publishing a report with over 50 recommendations. It concluded that e-cigarettes represent a valuable aid in smoking cessation, but that much more can and should be done to reduce their appeal, availability and affordability to people who do not smoke, including children and young people, and reduce environmental harms.
- 1
- 2
- 3
- 4
- …
- 41
- Go to the next page
